Total Payments
$58,967
2024 Payments
$6,842
Companies
9
Transactions
70
Medicare Patients
1,457
Medicare Billing
$955,507
Payment Breakdown by Category
Consulting$38,746 (65.7%)
Travel$15,095 (25.6%)
Food & Beverage$2,842 (4.8%)
Research$1,659 (2.8%)
Other$530.00 (0.9%)
Education$94.80 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,746 | 18 | 65.7% |
| Travel and Lodging | $15,095 | 11 | 25.6% |
| Food and Beverage | $2,842 | 32 | 4.8% |
| Unspecified | $1,659 | 7 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $530.00 | 1 | 0.9% |
| Education | $94.80 | 1 | 0.2% |
Payments by Type
General
$57,308
63 transactions
Research
$1,659
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $14,915 | 20 | $0 (2019) |
| Merz Pharmaceuticals GmbH | $12,217 | 7 | $0 (2017) |
| Ipsen Biopharmaceuticals, Inc | $10,941 | 6 | $0 (2021) |
| Merz Pharmaceuticals, LLC | $9,957 | 10 | $0 (2024) |
| Pacira Pharmaceuticals Incorporated | $9,644 | 14 | $0 (2024) |
| Saol Therapeutics Research Limited | $530.00 | 1 | $0 (2017) |
| Allergan Inc. | $497.41 | 7 | $0 (2018) |
| ABBVIE INC. | $244.76 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $19.66 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,842 | 10 | Merz Pharmaceuticals, LLC ($6,643) |
| 2023 | $7,982 | 12 | Pacira Pharmaceuticals Incorporated ($6,064) |
| 2022 | $5,022 | 6 | Pacira Pharmaceuticals Incorporated ($3,456) |
| 2021 | $3,670 | 2 | Ipsen Biopharmaceuticals, Inc ($3,650) |
| 2020 | $7,095 | 2 | Ipsen Biopharmaceuticals, Inc ($7,095) |
| 2019 | $2,249 | 15 | Merz North America, Inc. ($2,053) |
| 2018 | $12,958 | 7 | Merz North America, Inc. ($12,808) |
| 2017 | $13,149 | 16 | Merz Pharmaceuticals GmbH ($12,217) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $3,240.00 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $1,080.00 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $540.00 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Musculoskeletal | ||||||
| 11/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $43.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Pain Management | ||||||
| 10/26/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $115.27 | General |
| Category: Musculoskeletal | ||||||
| 02/23/2024 | Merz Pharmaceuticals, LLC | — | Food and Beverage | In-kind items and services | $27.34 | General |
| 01/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/04/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $1,620.00 | General |
| Category: Musculoskeletal | ||||||
| 11/16/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $146.00 | General |
| Category: Musculoskeletal | ||||||
| 10/03/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $1,960.00 | General |
| Category: Pain Management | ||||||
| 06/06/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $117.75 | General |
| Category: Pain Management | ||||||
| 05/11/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Pain Management | ||||||
| 04/20/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $1,706.25 | General |
| Category: Musculoskeletal | ||||||
| 02/24/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $65.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $153.11 | General |
| Category: Pain Management | ||||||
| 02/15/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $41.78 | General |
| Category: Pain Management | ||||||
| 02/14/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $65.52 | General |
| Category: Pain Management | ||||||
| 02/13/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $74.48 | General |
| Category: Pain Management | ||||||
| 02/12/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $99.16 | General |
| Category: Pain Management | ||||||
| 01/19/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Consulting Fee | Cash or cash equivalent | $1,102.50 | General |
| Category: Pain Management | ||||||
| 12/20/2022 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Consulting Fee | Cash or cash equivalent | $1,462.50 | General |
| Category: Musculoskeletal | ||||||
| 10/21/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $103.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2022 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $155.99 | General |
| Category: Pain Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NT 201 IN THE TREATMENT OF LOWER LIMB SPASTICITY CAUSED BY STROKE OR TRAUMATIC BRAIN INJURY IN ADULT SUBJECTS, FOLLOWED BY AN OPEN LABEL EXTENSION WITH OR WITHOUT COMBINED UPPER LIMB TREATMENT | Merz North America, Inc. | $1,659 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 316 | 38,952 | $595,049 | $219,616 |
| 2022 | 15 | 396 | 45,059 | $691,941 | $258,992 |
| 2021 | 15 | 381 | 44,956 | $716,315 | $265,453 |
| 2020 | 15 | 364 | 39,178 | $609,790 | $211,446 |
Total Patients
1,457
Total Services
168,145
Medicare Billing
$955,507
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 23,531 | $329,434 | $116,976 | 35.5% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2023 | 15 | 6,640 | $59,760 | $41,469 | 69.4% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 14 | 8,350 | $41,750 | $32,732 | 78.4% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 34 | 76 | $49,628 | $8,260 | 16.6% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 52 | 117 | $58,208 | $4,787 | 8.2% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 14 | 30 | $17,160 | $2,831 | 16.5% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 20 | 20 | $4,880 | $2,798 | 57.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 45 | $6,705 | $2,569 | 38.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 52 | 65 | $9,750 | $2,231 | 22.9% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 18 | 18 | $3,096 | $1,807 | 58.4% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 13 | 27 | $10,152 | $1,786 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,886 | $1,092 | 37.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 14 | 20 | $1,640 | $278.00 | 17.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 28 | 26,315 | $368,410 | $125,545 | 34.1% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2022 | 17 | 8,580 | $77,220 | $57,357 | 74.3% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 13 | 9,600 | $48,000 | $37,970 | 79.1% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 36 | 82 | $53,546 | $9,768 | 18.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 54 | 134 | $63,045 | $5,788 | 9.2% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2022 | 21 | 40 | $22,880 | $3,649 | 16.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 64 | $9,536 | $3,555 | 37.3% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 21 | 21 | $5,124 | $2,822 | 55.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 56 | 70 | $10,500 | $2,438 | 23.2% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2022 | 18 | 36 | $13,536 | $2,384 | 17.6% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 22 | 22 | $3,784 | $2,031 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 20 | $4,440 | $1,845 | 41.5% |
About Michael Munin
Michael Munin is a Specialist healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821062597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Munin has received a total of $58,967 in payments from pharmaceutical and medical device companies, with $6,842 received in 2024. These payments were reported across 70 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($38,746).
As a Medicare-enrolled provider, Munin has provided services to 1,457 Medicare beneficiaries, totaling 168,145 services with total Medicare billing of $955,507. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Pittsburgh, PA
- Active Since 02/17/2006
- Last Updated 04/06/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1821062597
Products in Payments
- Xeomin (Biological) $22,201
- XEOMIN (Biological) $14,737
- DYSPORT (Drug) $10,891
- Iovera (Device) $6,885
- Exparel (Drug) $2,759
- BOTOX (Biological) $694.26
- BOTOX CHRONIC MIGRAINE (Drug) $47.91
- Yupelri (Drug) $19.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pittsburgh
Dr. Lawrence Crossett, Md, MD
Specialist — Payments: $5.3M
Specialist $5.3M
Dr. James Bradley, Md, MD
Specialist — Payments: $5.0M
Specialist $5.0M
Darrell Triulzi
Specialist — Payments: $3.3M
Specialist $3.3M
Dr. Mark Yazer, Md, MD
Specialist — Payments: $2.4M
Specialist $2.4M
Lirong Qu
Specialist — Payments: $2.4M
Specialist $2.4M
Dr. Miguel Regueiro, Md, MD
Specialist — Payments: $1.4M
Specialist $1.4M